Genentech

Executive Provides Mentorship and Promotes Diversity at Genentech
Executive Provides Mentorship and Promotes Diversity at Genentech
BioSpace
diversity
Genentech
Roche
Flag link:
Layoffs Hit California Biopharma Companies
Layoffs Hit California Biopharma Companies
BioSpace
layoffs
Roche
Genentech
Pfizer
Aduro BioTech
Theravance
Merck
Flag link:
Judge skeptical of JHL's defense in Genentech case
Judge skeptical of JHL's defense in Genentech case
BioCentury
Genentech
JHL Biotech
trade secrets
Flag link:
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
BioSpace
Xofluza
Japan
Genentech
Flag link:
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics
Flag link:
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies
Flag link:
Report: five companies would take brunt of Trump Part B proposal
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Donald Trump
Medicare Part B
Amgen
Regeneron
Bristol-Myers Squibb
Genentech
Roche
Flag link:
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Genentech
Roche
Alexander Hardy
Pharma CEOs
Flag link:
Samsung Bioepis' First Cancer Biosimilar Approved by the FDA
Samsung Bioepis' First Cancer Biosimilar Approved by the FDA
BioSpace
FDA
Samsung Bioepis
Ontruzant
biosimilars
Genentech
Herceptin
Flag link:
Gilead, Genentech join PhRMA
Gilead, Genentech join PhRMA
BioCentury
PhRMA
Genentech
Gilead Sciences
Flag link:
Genentech Cutting More Jobs in Bay Area
Genentech Cutting More Jobs in Bay Area
BioSpace
Genentech
Roche
layoffs
Bay Area
Flag link:
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
BioSpace
Genentech
Proteostasis Therapeutics
small molecule drugs
Flag link:
Genentech develop antibiotic with potential to lead to new class of antibiotics
Genentech develop antibiotic with potential to lead to new class of antibiotics
Pharmaforum
Genentech
G07750
antibiotics
drug development
antibiotic resistance
Flag link:
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
clinical trials
Multiple Myeloma
adaptive trial design
AbbVie
Celgene
Eli Lilly
Genentech
Janssen
Takeda
Flag link:
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
Genentech Scores FDA Approval for Tecentriq and Avastin Combo in NSCLC
BioSpace
Genentech
FDA
Tecentriq
Avastin
non-squamous cell non-small cell lung cancer
Flag link:
Tecentriq could be first front-line SCLC therapy approved in two decades
Tecentriq could be first front-line SCLC therapy approved in two decades
BioCentury
FDA
Tecentriq
Genentech
extensive-stage small cell lung cancer
Flag link:
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Xconomy
Roche
Jecure Therapeutics
M&A
NASH
Genentech
Flag link:
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Roche
Genentech
Venclexta
FDA
AML
acute myeloid leukemia
Flag link:

Pages